Urbano
Anido Herranz
Queen Mary University of London
Londres, Reino UnidoPublications in collaboration with researchers from Queen Mary University of London (3)
2022
-
Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder
European Urology, Vol. 82, Núm. 2, pp. 212-222